External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology APAO 2026
Roche and Genentech at

APAO 2026

February 05 - February 08
Hong Kong, China
2026.apaophth.org
We will be contributing to topics related to
Ophthalmology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
01:05 AM
Duration 5mins China
Primary Results of the Phase-3 SatraGO-1 and SatraGO 2 Trials: Efficacy and Safety of Satralizumab▼ in Thyroid Eye Disease
Li Dongmei
Ophthalmology | Thyroid eye disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:05 AM
Duration 5mins Singapore
Comparative Efficacy of Faricimab▼ for the Treatment of Diabetic Macular Edema at 1 and 2 Years: A Systematic Literature Review and Network Meta-Analysis
Colin Tan
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:10 AM
Duration 5mins Malaysia
Effectiveness and Safety of Faricimab▼ in nAMD (Neovascular Age-Related Macular Degeneration) and DME (Diabetic Macular Edema) Eyes Beyond Year-1: UK FARWIDE-nAMD and FARWIDE-DME Study Results
Kenneth Fong
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:25 AM
Duration 5mins China
Faricimab▼ for PCV (Polypoidal Choroidal Vasculopathy): One-Year Ethnically Chinese Subgroup Results from Phase-3b/4 SALWEEN Trial
Ming Zhang
Ophthalmology | Polypoidal Choroidal Vasculopathy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:00 AM
Duration 5mins Singapore
Predictors of Extended Treatment Interval in DME (Diabetic Macular Edema) Patients Treated With Faricimab▼ in the Phase-3 YOSEMITE/RHINE Trials
Anna Tan
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Korea
Intraretinal and Subretinal Fluid Resolution With Vamikibart in Uveitic Macular Edema: Phase-1 DOVETAIL Exploratory Results
Iksoo Byon
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:30 AM
Duration 5mins Taiwan
Interleukin-6 Inhibition With Vamikibart in Patients With Uveitic Macular Edema: Data From Phase-3 MEERKAT and SANDCAT trials
Yih-Shiou Hwang
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:40 AM
Duration 5mins Taiwan
Machine Learning–Based 3D Volumetric Analysis of Pigment Epithelial Detachment Reduction With Faricimab▼ vs Aflibercept in TENAYA/LUCERNE
Ling Yeung
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:05 AM
Duration 5mins Thailand
Real-World Faricimab▼ Outcomes in nAMD (Neovascular Age-Related Macular Degeneration) and DME (Diabetic Macular Edema): The VOYAGER Study
Voraporn Chaikitmongkol
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:25 AM
Duration 5mins Singapore
Long-Term Efficacy and Safety of PDS (Port Delivery Platform With Ranibizumab) in Patients With nAMD (Neovascular Age-related Macular Degeneration): Results From the Ladder- and Archway-to-Portal Trials
Yuen Yew Sen
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:40 AM
Duration 5mins Australia
Association of Early Macular Leakage Resolution with Extended Dosing Intervals in Patients With RVO (Retinal Vein Occlusion): A Post-Hoc Analysis of the BALATON/COMINO Trials
Hemal Mehta
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:55 AM
Duration 5mins Korea
Impact of the Optimization of Surgical Procedure on the Incidence of Endophthalmitis and Associated Patient Outcomes in Port Delivery Platform with Ranibizumab Trials
SeJoon Woo
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:35 AM
Duration 5mins Korea
Baseline and Early Treatment Response Variables of Faricimab▼ Durability in Treatment-Naïve nAMD (Neovascular Age-Related Macular Degeneration)
JiHun Song
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:10 AM
Duration 5mins Hong Kong
Automated Quantification of Retinal Fluid in Patients with Diabetic Macular Edema: Analysis of Faricimab▼ vs Aflibercept in YOSEMITE/RHINE
Simon Szeto
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:50 AM
Duration 5mins Japan
Update on Faricimab▼ for Diabetic Macular Edema: New Clinical Features of Eyes in the RHONE-X Long-Term Extension Study
Toshinori Murata
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:00 AM
Duration 5mins Thailand
Faricimab▼ for Polypoidal Choroidal Vasculopathy: One-Year Results From the Phase-3b/4 SALWEEN Trial
Paisan Rumaviboonsuk
Ophthalmology | Polypoidal Choroidal Vasculopathy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:15 AM
Duration 5mins Taiwan
Impact of PDS (Port Delivery Platform With Ranibizumab) in Study Eyes vs Anti-VEGF (Vascular Endothelial Growth Factor) in Fellow-Eyes on Efficacy and Safety Outcomes in Bilateral DME (Diabetic Macular Edema) in Pagoda
Yi-Ting Hsieh
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:35 AM
Duration 5mins Hong Kong
Four-Year Outcomes of Faricimab▼ in Neovascular Age-Related Macular Degeneration: Safety and Efficacy From the AVONELLE-X Long-Term Extension Trial
Timothy Lai
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:15 AM
Duration 5mins Taiwan
Greater Anatomical Improvements With Faricimab▼ vs Aflibercept 8 Weeks After Injections: A TENAYA/LUCERNE Post-Hoc Analysis
Tai-Chi Lin
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.